Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

ClinicalTrials.gov ID: NCT00359801

Public ClinicalTrials.gov record NCT00359801. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International, Multicenter, Large Simple Trial To Evaluate The Long-Term Pulmonary And Cardiovascular Safety Of Exubera In Patients With Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term pulmonary and cardiovascular safety of Exubera in routine clinical practice.

Study identification

NCT ID
NCT00359801
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
1,976 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2006 (Type not available)
Primary completion
Dec 2008 (Actual)
Completion
Apr 2009 (Actual)
Last update posted
Feb 2, 2010

2006 – 2009

United States locations

U.S. sites
132
U.S. states
37
U.S. cities
124
Facility City State ZIP Site status
Pfizer Investigational Site Bay Minette Alabama 36507-4185 —
Pfizer Investigational Site Fairhope Alabama 36532 —
Pfizer Investigational Site Graysville Alabama 35073 —
Pfizer Investigational Site Pell City Alabama 35125 —
Pfizer Investigational Site Phoenix Arizona 85016 —
Pfizer Investigational Site Phoenix Arizona 85028 —
Pfizer Investigational Site Phoenix Arizona 85029 —
Pfizer Investigational Site Forrest City Arkansas 72335 —
Pfizer Investigational Site Searcy Arkansas 72143 —
Pfizer Investigational Site Cudahy California 90201 —
Pfizer Investigational Site El Cajon California 92019 —
Pfizer Investigational Site Huntington Beach California 92648 —
Pfizer Investigational Site Rolling Hills Estates California 90274 —
Pfizer Investigational Site San Jose California 95116 —
Pfizer Investigational Site Santa Ana California 92704 —
Pfizer Investigational Site Westminster California 92683 —
Pfizer Investigational Site Denver Colorado 80219 —
Pfizer Investigational Site Milford Connecticut 06460 —
Pfizer Investigational Site Wilmington Delaware 19806 —
Pfizer Investigational Site Boca Raton Florida 33433 —
Pfizer Investigational Site Clearwater Florida 33756 —
Pfizer Investigational Site DeBary Florida 32713 —
Pfizer Investigational Site Gainesville Florida 32605 —
Pfizer Investigational Site Green Cove Springs Florida 32043 —
Pfizer Investigational Site Hollywood Florida 33021 —
Pfizer Investigational Site Kissimmee Florida 34741 —
Pfizer Investigational Site Kissimmee Florida 34743 —
Pfizer Investigational Site Marianna Florida 32446 —
Pfizer Investigational Site Merritt Island Florida 32952 —
Pfizer Investigational Site Miami Florida 33144 —
Pfizer Investigational Site Niceville Florida 32578 —
Pfizer Investigational Site Opa-locka Florida 33054-3818 —
Pfizer Investigational Site Orange City Florida 32763 —
Pfizer Investigational Site Ormond Beach Florida 32174 —
Pfizer Investigational Site Pembroke Pines Florida 33027 —
Pfizer Investigational Site Plantation Florida 33324 —
Pfizer Investigational Site Port Charlotte Florida 33952 —
Pfizer Investigational Site Tampa Florida 33607 —
Pfizer Investigational Site Tampa Florida 33624 —
Pfizer Investigational Site Atlanta Georgia 30318-2513 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Conyers Georgia 30013 —
Pfizer Investigational Site Decatur Georgia 30035 —
Pfizer Investigational Site Warner Robins Georgia 31088 —
Pfizer Investigational Site Boise Idaho 83704 —
Pfizer Investigational Site Greenville Illinois 62246 —
Pfizer Investigational Site Libertyville Illinois 60048 —
Pfizer Investigational Site Fishers Indiana 46038 —
Pfizer Investigational Site Indianapolis Indiana 46229 —
Pfizer Investigational Site Indianapolis Indiana 46254-5472 —
Pfizer Investigational Site Des Moines Iowa 50315 —
Pfizer Investigational Site Louisville Kentucky 40258 —
Pfizer Investigational Site Mount Sterling Kentucky 40353 —
Pfizer Investigational Site Bossier City Louisiana 71111 —
Pfizer Investigational Site Auburn Maine 04210 —
Pfizer Investigational Site Baltimore Maryland 21204 —
Pfizer Investigational Site Elkton Maryland 21921 —
Pfizer Investigational Site Glen Burnie Maryland 21061 —
Pfizer Investigational Site Wheaton Maryland 20902 —
Pfizer Investigational Site Boston Massachusetts 02110 —
Pfizer Investigational Site Plymouth Massachusetts 02360 —
Pfizer Investigational Site Ann Arbor Michigan 48104 —
Pfizer Investigational Site Battle Creek Michigan 49014 —
Pfizer Investigational Site Battle Creek Michigan 49017 —
Pfizer Investigational Site Clinton Michigan 49236 —
Pfizer Investigational Site Flint Michigan 48504 —
Pfizer Investigational Site Muskegon Michigan 49444 —
Pfizer Investigational Site Sterling Heights Michigan 48310 —
Pfizer Investigational Site Troy Michigan 48084 —
Pfizer Investigational Site Warren Michigan 48091 —
Pfizer Investigational Site Saint Cloud Minnesota 56301 —
Pfizer Investigational Site Grand Island Nebraska 68803 —
Pfizer Investigational Site Incline Village Nevada 89452 —
Pfizer Investigational Site Belleville New Jersey 07109 —
Pfizer Investigational Site Belvidere New Jersey 07823 —
Pfizer Investigational Site Glendora New Jersey 08029 —
Pfizer Investigational Site Albuquerque New Mexico 87106 —
Pfizer Investigational Site Babylon New York 11702 —
Pfizer Investigational Site Brooklyn New York 11224 —
Pfizer Investigational Site New Hartford New York 13413 —
Pfizer Investigational Site Rochester New York 14622 —
Pfizer Investigational Site Williamsville New York 14221 —
Pfizer Investigational Site Asheboro North Carolina 27203 —
Pfizer Investigational Site Charlotte North Carolina 28227 —
Pfizer Investigational Site Morehead City North Carolina 28557-3126 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Raleigh North Carolina 27610 —
Pfizer Investigational Site Shelby North Carolina 28150 —
Pfizer Investigational Site Tabor City North Carolina 28463 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Bismarck North Dakota 58501 —
Pfizer Investigational Site Ashtabula Ohio 44004 —
Pfizer Investigational Site Canton Ohio 44708 —
Pfizer Investigational Site Cleveland Ohio 44113 —
Pfizer Investigational Site Columbus Ohio 43207 —
Pfizer Investigational Site Dayton Ohio 45419 —
Pfizer Investigational Site McConnelsville Ohio 43756 —
Pfizer Investigational Site Zanesville Ohio 43701 —
Pfizer Investigational Site Clinton Oklahoma 73601 —
Pfizer Investigational Site Bend Oregon 97701 —
Pfizer Investigational Site Broomall Pennsylvania 19008 —
Pfizer Investigational Site Dauphin Pennsylvania 17018 —
Pfizer Investigational Site Fogelsville Pennsylvania 18051 —
Pfizer Investigational Site Hanover Pennsylvania 17331 —
Pfizer Investigational Site Harrisburg Pennsylvania 17112 —
Pfizer Investigational Site Jeannette Pennsylvania 15644 —
Pfizer Investigational Site Jenkintown Pennsylvania 19046 —
Pfizer Investigational Site Jersey Shore Pennsylvania 17740 —
Pfizer Investigational Site Norristown Pennsylvania 19401 —
Pfizer Investigational Site Philadelphia Pennsylvania 19153-2326 —
Pfizer Investigational Site Plymouth Meeting Pennsylvania 19462 —
Pfizer Investigational Site Tipton Pennsylvania 16684 —
Pfizer Investigational Site Charleston South Carolina 29412 —
Pfizer Investigational Site Florence South Carolina 29501 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site North Myrtle Beach South Carolina 29582 —
Pfizer Investigational Site Germantown Tennessee 38138 —
Pfizer Investigational Site Corpus Christi Texas 78414 —
Pfizer Investigational Site Garland Texas 75041 —
Pfizer Investigational Site Hurst Texas 76054 —
Pfizer Investigational Site Kaufman Texas 75142 —
Pfizer Investigational Site Lubbock Texas 79410 —
Pfizer Investigational Site Midland Texas 79705 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site San Marcos Texas 78666 —
Pfizer Investigational Site Stephenville Texas 76401 —
Pfizer Investigational Site Webster Texas 77598 —
Pfizer Investigational Site Layton Utah 84041 —
Pfizer Investigational Site Chesapeake Virginia 23320 —
Pfizer Investigational Site Ettrick Virginia 23803 —
Pfizer Investigational Site Burnsville West Virginia 26335 —
Pfizer Investigational Site Charleston West Virginia 25314 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00359801, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2010 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00359801 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →